Lefamulin Side Effects
Medically reviewed by Drugs.com. Last updated on Sep 27, 2024.
Applies to lefamulin: intravenous solution.
Other dosage forms:
Common side effects of lefamulin
Some side effects of lefamulin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- pain, itching, burning, swelling, or a lump at the injection site
Less common side effects
- headache
- trouble sleeping
Serious side effects of lefamulin
Along with its needed effects, lefamulin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking lefamulin:
Less common side effects
- convulsions
- decreased urine
- dry mouth
- increased thirst
- irregular heartbeat
- loss of appetite
- mood changes
- muscle pain or cramps
- nausea or vomiting
- numbness or tingling in the hands, feet, or lips
- trouble breathing
- unusual tiredness or weakness
Incidence not known
- abdominal or stomach tenderness
- chest pain or discomfort
- fainting
- fever
- irregular or slow heart rate
- severe abdominal or stomach cramps and pain
- watery and severe diarrhea, which may also be bloody
For healthcare professionals
Applies to lefamulin: intravenous solution, oral tablet.
Gastrointestinal adverse events
- Very common (10% or more): Diarrhea (up to 12%)
- Common (1% to 10%): Nausea, vomiting
- Frequency not reported: Abdominal pain, constipation, dyspepsia, epigastric discomfort, erosive gastritis, Clostridium difficile-associated diarrhea, C difficile colitis, oropharyngeal candidiasis[Ref]
Local
- Common (1% to 10%): Administration site reactions (included infusion site pain, infusion site phlebitis, injection site reaction)[Ref]
Hepatic
- Common (1% to 10%): Hepatic enzyme elevation (included increased ALT, increased AST, increased liver function test)
- Frequency not reported: Increased GGT[Ref]
Metabolic
- Common (1% to 10%): Hypokalemia[Ref]
Psychiatric
Nervous system
- Common (1% to 10%): Headache
- Frequency not reported: Somnolence[Ref]
Other
- Common (1% to 10%): Death within 28 days
- Frequency not reported: Increased alkaline phosphatase[Ref]
Death within 28 days occurred in 1.2% of patients treated with this drug and 1.1% of patients treated with moxifloxacin.[Ref]
Cardiovascular
- Frequency not reported: Atrial fibrillation, palpitations, prolonged QT on ECG[Ref]
Genitourinary
- Frequency not reported: Vulvovaginal candidiasis, urinary retention[Ref]
Hematologic
- Frequency not reported: Anemia, thrombocytopenia[Ref]
Musculoskeletal
References
1. (2019) "Product Information. Xenleta (lefamulin)." Nabriva Therapeutics US, Inc.
More about lefamulin
- Check interactions
- Compare alternatives
- Reviews (1)
- Dosage information
- During pregnancy
- Drug class: miscellaneous antibiotics
- Breastfeeding
- En español
Patient resources
- Lefamulin oral/injection drug information
- Lefamulin (Intravenous) (Advanced Reading)
- Lefamulin (Oral) (Advanced Reading)
- Lefamulin Tablets
- Lefamulin Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Lefamulin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.